Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-30 @ 2:12 AM
Study NCT ID:
NCT00676832
Status:
COMPLETED
Last Update Posted:
2010-09-29
First Post:
2008-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
Sponsor:
Prometheus Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
08CP01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Emil Chuang, Sr. Medical Director, GI Clinical Dev & Med Affairs
Old Organization:
Prometheus Laboratories, Inc.